Prime Therapeutics CEO Jim DuCharme is Retiring
Prime Therapeutics president and CEO Jim DuCharme. ( Photo by Prime Therapeutics)

Prime Therapeutics CEO Jim DuCharme is Retiring

The Eagan-based pharmacy benefit manager hopes to have a successor picked before DuCharme’s exit in March 2019.

The nation’s fifth largest pharmacy benefit manager, Eagan-based Prime Therapeutics, will lose its president and CEO in the first quarter of the new year.

Jim DuCharme, who took over the top leadership post at Prime four years ago after a two-year stint as the company’s CFO, announced his intention to retire on Tuesday. He’s scheduled his final day with Prime to be March 1, 2019 to allow his employer time to find a replacement.

Prime spokeswoman Karen Lyons says a national search is expected to launch “shortly.”

In his years leading Prime, DuCharme shepherded major projects through the pipeline, including a partnership with Walgreens and the creation of a new corporate campus in Eagan.

Today, Prime serves more than 27 million members around the nation—a figure that has grown by 30 percent over the past two years. The company, which got its start 20 years ago managing pharmacy claims for Blue Cross and Blue Shield of Minnesota, is now collectively owned by 18 Blue Cross and Blue Shield health plans.

More than 2,100 of Prime’s 3,600 employees are located in Eagan and Bloomington.